Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia

被引：20

作者：

Annunziata, Mario ^{[1
]}

Bonifacio, Massimiliano ^{[2
]}

Breccia, Massimo ^{[3
]}

Castagnetti, Fausto ^{[4
]}

Gozzini, Antonella ^{[5
]}

Iurlo, Alessandra ^{[6
]}

Pregno, Patrizia ^{[7
]}

Stagno, Fabio ^{[8
]}

Specchia, Giorgina ^{[9
]}

机构：

[1] AORN Cardarelli Napoli, Hematol Div, Naples, Italy

[2] Univ Verona, Dept Med, Sect Hematol, Verona, Italy

[3] Sapienza Univ, Dept Translat & Precis Med, Rome, Italy

[4] Univ Bologna, S Orsola Malpighi Univ Hosp, Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[5] AUO Careggi, Dept Cellular Therapy & Transfus Med, Florence, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Div, Milan, Italy

[7] AOU Citta Salute & Sci Torino, Hematol Div, Oncol & Hematol Dept, Turin, Italy

[8] AOU Policlin V Emanuele, Div Hematol & Bone Marrow Transplant, Catania, Italy

[9] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Hematol Sect, Bari, Italy

来源：

FRONTIERS IN ONCOLOGY | 2020年 / 10卷

关键词：

chronic myeloid leukemia; deep molecular response; optimal strategies; treatment-free remission; tyrosine kinase inhibitors; TYROSINE KINASE INHIBITORS; IMATINIB DISCONTINUATION; FRONTLINE NILOTINIB; CLINICAL-PRACTICE; PEGINTERFERON ALPHA-2A; INTERFERON-ALPHA; RANDOMIZED-TRIAL; CML PATIENTS; DASATINIB; BCR-ABL1;

D O I：

10.3389/fonc.2020.00883

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The treatment of chronic myeloid leukemia (CML) has been radically changed by the approval of tyrosine kinase inhibitors (TKIs), which target BCR-ABL1 kinase activity. CML is now managed as a chronic disease requiring long-term treatment and close molecular monitoring. It has been shown that in a substantial number of patients who have achieved a stable deep molecular response (DMR), TKI treatment can be safely discontinued without loss of response. Therefore, treatment-free remission (TFR), through the achievement of a DMR, is increasingly regarded as a feasible treatment goal in many CML patients. However, only nilotinib has approval in this setting and a number of controversial aspects remain regarding treatment choices and timings, predictive factors, patient communication, and optimal strategies to achieve successful TFR. This narrative review aims to provide a comprehensive overview on how to optimize the path to DMR and TFR in patients with CML, and discusses recent data and future directions.

引用

页数：12

共 98 条

[1] Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia [J].

Alfayez, Mansour ;

Richard-Carpentier, Guillaume ;

Jabbour, Elias ;

Vishnu, Prakash ;

Naqvi, Kiran ;

Sasaki, Koji ;

Cortes, Jorge ;

Pemmaraju, Naveen .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (04) :543-545

[2] Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP [J].

Baccarani, Michele ;

Abruzzese, Elisabetta ;

Accurso, Vincenzo ;

Albano, Francesco ;

Annunziata, Mario ;

Barulli, Sara ;

Beltrami, Germana ;

Bergamaschi, Micaela ;

Binotto, Gianni ;

Bocchia, Monica ;

Caocci, Giovanni ;

Capodanno, Isabella ;

Cavazzini, Francesco ;

Cedrone, Michele ;

Cerrano, Marco ;

Crugnola, Monica ;

D'Adda, Mariella ;

Elena, Chiara ;

Fava, Carmen ;

Fazi, Paola ;

Fozza, Claudio ;

Galimberti, Sara ;

Giai, Valentina ;

Gozzini, Antonella ;

Gugliotta, Gabriele ;

Iurlo, Alessandra ;

La Barba, Gaetano ;

Levato, Luciano ;

Lucchesi, Alessandro ;

Luciano, Luigia ;

Lunghi, Francesca ;

Lunghi, Monia ;

Malagola, Michele ;

Marasca, Roberto ;

Martino, Bruno ;

Melpignano, Angela ;

Miggiano, Maria Cristina ;

Montefusco, Enrico ;

Musolino, Caterina ;

Palmieri, Fausto ;

Pregno, Patrizia ;

Rapezzi, Davide ;

Rege-Cambrin, Giovanna ;

Rupoli, Serena ;

Salvucci, Marzia ;

Sancetta, Rosaria ;

Sica, Simona ;

Spadano, Raffaele ;

Stagno, Fabio ;

Tiribelli, Mario .

BLOOD ADVANCES, 2019, 3 (24) :4280-4290

[3] Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type [J].

Baccarani, Michele ;

Rosti, Gianantonio ;

Soverini, Simona .

LEUKEMIA, 2019, 33 (10) :2358-2364

[4] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].

Baccarani, Michele ;

Deininger, Michael W. ;

Rosti, Gianantonio ;

Hochhaus, Andreas ;

Soverini, Simona ;

Apperley, Jane F. ;

Cervantes, Francisco ;

Clark, Richard E. ;

Cortes, Jorge E. ;

Guilhot, Francois ;

Hjorth-Hansen, Henrik ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kim, Dong-Wook ;

Larson, Richard A. ;

Lipton, Jeffrey H. ;

Mahon, Francois-Xavier ;

Martinelli, Giovanni ;

Mayer, Jiri ;

Mueller, Martin C. ;

Niederwieser, Dietger ;

Pane, Fabrizio ;

Radich, Jerald P. ;

Rousselot, Philippe ;

Saglio, Giuseppe ;

Saussele, Susanne ;

Schiffer, Charles ;

Silver, Richard ;

Simonsson, Bengt ;

Steegmann, Juan-Luis ;

Goldman, John M. ;

Hehlmann, Ruediger .

BLOOD, 2013, 122 (06) :872-884

[5] Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome [J].

Berger, Marc G. ;

Pereira, Bruno ;

Rousselot, Philippe ;

Cony-Makhoul, Pascale ;

Gardembas, Martine ;

Legros, Laurence ;

Escoffre-Barbe, Martine ;

Nicolini, Franck-Emmanuel ;

Saugues, Sandrine ;

Lambert, Celine ;

Rea, Delphine ;

Guerci-Bresler, Agnes ;

Giraudier, Stephane ;

Guilhot, Joelle ;

Saussele, Susanne ;

Mahon, Francois-Xavier .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (03) :337-346

[6] Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation [J].

Bernardi, Simona ;

Malagola, Michele ;

Zanaglio, Camilla ;

Polverelli, Nicola ;

Eke, Elif Dereli ;

DAdda, Marietta ;

Farina, Mirko ;

Bucelli, Cristina ;

Scaffidi, Luigi ;

Toffoletti, Eleonora ;

Deambrogi, Clara ;

Stagno, Fabio ;

Bergamaschi, Micaela ;

Franceschini, Luca ;

Abruzzese, Elisabetta ;

Divona, Maria Domenica ;

Gobbi, Marco ;

Di Raimondo, Francesco ;

Gaidano, Gianluca ;

Tiribelli, Mario ;

Bonifacio, Massimiliano ;

Cattanco, Chiara ;

Iurlo, Alessandra ;

Russo, Domenico .

CANCER MEDICINE, 2019, 8 (05) :2041-2055

[7] Prospective Monitoring of Peripheral Blood CD26+Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation [J].

Bocchia, Monica ;

Sicuranza, Anna ;

Pacelli, Paola ;

Pregno, Patrizia ;

Annunziata, Mario ;

Sora, Federica ;

Abruzzese, Elisabetta ;

Crugnola, Monica ;

Luciano, Luigiana ;

Iurlo, Alessandra ;

Galimberti, Sara ;

Liberati, Anna Marina ;

Ferrigno, Ilaria ;

Ciofini, Sara ;

Defina, Marzia ;

Puccetti, Luca ;

Raspadori, Donatella .

BLOOD, 2019, 134

[8] Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial [J].

Borghi, Lidia ;

Galimberti, Sara ;

Barate, Claudia ;

Bonifacio, Massimiliano ;

Capochiani, Enrico ;

Cuneo, Antonio ;

Falzetti, Franca ;

Iurlo, Alessandra ;

Lunghi, Francesca ;

Minotto, Claudia ;

Orlandi, Ester Maria ;

Rege-Cambrin, Giovanna ;

Sica, Simona ;

Supekar, Sharon ;

Haenig, Jens ;

Vegni, Elena .

FRONTIERS IN PSYCHOLOGY, 2019, 10

[9] Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML [J].

Branford, Susan ;

Yeung, David T. ;

Ross, David M. ;

Prime, Jodi A. ;

Field, Chani R. ;

Altamura, Haley K. ;

Yeoman, Alexandra L. ;

Georgievski, Jasmina ;

Jamison, Bronte A. ;

Phillis, Stuart ;

Sullivan, Brad ;

Briggs, Nancy E. ;

Hertzberg, Mark ;

Seymour, John F. ;

Reynolds, John ;

Hughes, Timothy P. .

BLOOD, 2013, 121 (19) :3818-3824

[10] Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life [J].

Breccia, Massimo ;

Colafigli, Gioia ;

Molica, Matteo ;

Scalzulli, Emilia ;

Diverio, Daniela ;

Latagliata, Roberto ;

Guarini, Anna ;

Foa, Robin .

AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) :E668-E670

← 1 2 3 4 5 6 7 8 9 10 →